|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Research and development expenses | |
| General and administrative expenses | |
| Total operating expenses | |
| Operating loss | |
| Other expense – direct listing offering costs | |
| Net loss and comprehensive loss | |
| Net loss per share – basic | |
| Net loss per share – diluted | |
| Weighted average common shares outstanding – basic | |
| Weighted average common shares outstanding – diluted |
Loading...
